CoChat

Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Using LC/qTOF-MS we detected lumisterol, 20-hydroxylumisterol, 22-hydroxylumisterol, 24-hydroxylumisterol, 20,22-dihydroxylumisterol, pregnalumisterol, 17-hydroxypregnalumisterol and 17,20-dihydroxypregnalumisterol in human serum and epidermis, and the porcine adrenal gland. The hydroxylumisterols inhibited proliferation of human skin cells in a cell type-dependent fashion with predominant effects on epidermal keratinocytes. They also inhibited melanoma proliferation in both monolayer and soft agar. 20-Hydroxylumisterol stimulated the expression of several genes, including those associated with keratinocyte differentiation and antioxidative responses, while inhibiting the expression of others including RORA and RORC. Molecular modeling and studies on VDRE-transcriptional activity excludes action through the genomic site of the VDR. However, their favorable interactions with the A-pocket in conjunction with VDR translocation studies suggest they may act on this non-genomic VDR site. Inhibition of RORα and RORγ transactivation activities in a Tet-on CHO cell reporter system, RORα co-activator assays and inhibition of (RORE)-LUC reporter activity in skin cells, in conjunction with molecular modeling, identified RORα and RORγ as excellent receptor candidates for the hydroxylumisterols. Thus, we have discovered a new biologically relevant, lumisterogenic pathway, the metabolites of which display biological activity. This opens a new area of endocrine research on the effects of the hydroxylumisterols on different pathways in different cells and the mechanisms involved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-10202-7

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Detection of vitamin D3 (D3), lumisterol3 (L3) and 7-dehydrocholesterol (7DHC) in human epidermis (A), human serum (B) and pig adrenal grand (C). Extracted ion chromatograms (EIC) on qTOF LC-MS using m/z = 367.3 [M + H-H2O]+ are shown. The extraction and LC-MS conditions are described in Materials and Methods.
Figure 1 Detection of vitamin D3 (D3), lumisterol3 (L3) and 7-dehydrocholesterol (7DHC) in human epidermis (A), human serum (B) and pig adrenal grand (C). Extracted ion chromatograms (EIC) on qTOF LC-MS using m/z = 367.3 [M + H-H2O]+ are shown. The extraction and LC-MS conditions are described in Materials and Methods.CC BY · PubMed Central
Figure 2 Detection of hydroxyl L3 derivatives in human epidermis (A) and human serum (B). Extracted ion chromatograms (EIC) on qTOF LC-MS are shown using m/z = 383.3 [M + H-H2O]+ for 20(OH)L3 (epidermis and serum), 22(OH)L3 (serum) and 24(OH)L3 (epidermis); 401.3 [M + H]+ for 22(OH)L3 (serum) and 24(OH)L3 (epidermis); 439.3 [M + Na]+ for 20,22(OH)2L3 (epidermis); 417.3 [M + H]+ for 20,22(OH)2L3 (serum). Inserts are mass spectra recorded on each indicated peak. The extraction and LC-MS conditions are described in Materials and Methods.
Figure 2 Detection of hydroxyl L3 derivatives in human epidermis (A) and human serum (B). Extracted ion chromatograms (EIC) on qTOF LC-MS are shown using m/z = 383.3 [M + H-H2O]+ for 20(OH)L3 (epidermis and serum), 22(OH)L3 (serum) and 24(OH)L3 (epidermis); 401.3 [M + H]+ for 22(OH)L3 (serum) and 24(OH)L3 (epidermis); 439.3 [M + Na]+ for 20,22(OH)2L3 (epidermis); 417.3 [M + H]+ for 20,22(OH)2L3 (serum). Inserts are mass spectra recorded on each indicated peak. The extraction and LC-MS conditions are described in Materials and Methods.CC BY · PubMed Central
Figure 3 Detection of hydroxyl pL derivatives in human epidermis (A) and human serum (B). Extracted ion chromatograms (EIC) on qTOF LC-MS are shown using m/z = 297.2 [M + H-H2O]+ for pL (epidermis and serum); 313.2 [M + H-H2O]+ for 17(OH)pL (epidermis and serum); 333.2 [M + H]+ for 17,20(OH)2pL (epidermis); 315.2 [M + H-H2O]+ for 17,20(OH)2pL (serum). Mass spectra detected in each samples are shown below EICs. The extraction and LC-MS conditions are described in Materials and Methods.
Figure 3 Detection of hydroxyl pL derivatives in human epidermis (A) and human serum (B). Extracted ion chromatograms (EIC) on qTOF LC-MS are shown using m/z = 297.2 [M + H-H2O]+ for pL (epidermis and serum); 313.2 [M + H-H2O]+ for 17(OH)pL (epidermis and serum); 333.2 [M + H]+ for 17,20(OH)2pL (epidermis); 315.2 [M + H-H2O]+ for 17,20(OH)2pL (serum). Mass spectra detected in each samples are shown below EICs. The extraction and LC-MS conditions are described in Materials and Methods.CC BY · PubMed Central
Figure 4 Inhibition of keratinocytes proliferation by 20(OH)L3, 22(OH)L3, 24(OH)L3 and 20,22(OH)2L3. (A), MTS assay with HaCaT keratinocytes. The cells were synchronized by precincubation with serum-free media for 24 h, which was then replaced with DMEM plus 5% charcoal-treated FBS, and graded concentrations of hydroxylumisterols. After 48 h, the plates were used for the MTS assay performed at 490 nm. (B), SRB assay with primary normal human epidermal keratinocytes. After 24 h of culture, fresh keratinocyte media containing graded concentrations of 20(OH)L3 were added. After 24 or 48 h, the plates were processed for SRB assays performed at 570 nm. Data represent means ± SE (n ≥ 3) where *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 at student t-test; and #p < 0.05, ##p < 0.01 and ####p < 0.0001 at one-way ANOVA test and general ANOVA tests are shown.
Figure 4 Inhibition of keratinocytes proliferation by 20(OH)L3, 22(OH)L3, 24(OH)L3 and 20,22(OH)2L3. (A), MTS assay with HaCaT keratinocytes. The cells were synchronized by precincubation with serum-free media for 24 h, which was then replaced with DMEM plus 5% charcoal-treated FBS, and graded concentrations of hydroxylumisterols. After 48 h, the plates were used for the MTS assay performed at 490 nm. (B), SRB assay with primary normal human epidermal keratinocytes. After 24 h of culture, fresh keratinocyte media containing graded concentrations of 20(OH)L3 were added. After 24 or 48 h, the plates were processed for SRB assays performed at 570 nm. Data represent means ± SE (n ≥ 3) where *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 at student t-test; and #p < 0.05, ##p < 0.01 and ####p < 0.0001 at one-way ANOVA test and general ANOVA tests are shown.CC BY · PubMed Central
Figure 5 Inhibition of SKMEL-188 human melanoma growth by 20(OH)L3, 22(OH)L3, 24(OH)L3 and 20,22(OH)2L3. (A), Inhibition of proliferation in monolayer assed by MTS assay. After 24 h of culture, the cells were exposed to graded concentrations of hydroxylumisterols suspended in Ham’s F10 plus 10% charcoal-treated FBS. After 48 h, the plates were used for MTS assay performed at 490 nm. (B), Inhibition of growth in soft agar (anchorage independent growth). Melanoma cells were suspended in medium containing 0.4% agarose (American Bioanalytical, Natick, MA) and 5% charcoal-treated FBS, and seeded at 1,000 cells/well in a 0.8% agar layer in 24-well plates and treated with the graded concentrations of the listed compounds which were freshly added every 72 h over 13 days54. The colonies stained with MTT reagent (Promega, Madison, WI) were analyzed using the Cytation 5 Cell Imaging Multi-Mode Reader in three different z-planes and scored using Gen5 software54. Data represent means ± SE (n ≥ 3) where *p < 0.05, **p < 0.01 and ***p < 0.001 by the student t-test, and general ANOVA tests are shown.
Figure 5 Inhibition of SKMEL-188 human melanoma growth by 20(OH)L3, 22(OH)L3, 24(OH)L3 and 20,22(OH)2L3. (A), Inhibition of proliferation in monolayer assed by MTS assay. After 24 h of culture, the cells were exposed to graded concentrations of hydroxylumisterols suspended in Ham’s F10 plus 10% charcoal-treated FBS. After 48 h, the plates were used for MTS assay performed at 490 nm. (B), Inhibition of growth in soft agar (anchorage independent growth). Melanoma cells were suspended in medium containing 0.4% agarose (American Bioanalytical, Natick, MA) and 5% charcoal-treated FBS, and seeded at 1,000 cells/well in a 0.8% agar layer in 24-well plates and treated with the graded concentrations of the listed compounds which were freshly added every 72 h over 13 days54. The colonies stained with MTT reagent (Promega, Madison, WI) were analyzed using the Cytation 5 Cell Imaging Multi-Mode Reader in three different z-planes and scored using Gen5 software54. Data represent means ± SE (n ≥ 3) where *p < 0.05, **p < 0.01 and ***p < 0.001 by the student t-test, and general ANOVA tests are shown.CC BY · PubMed Central
Figure 6 Modulation of RORα and RORγ activities by 20(OH)L3, 22(OH)L3, 24(OH)L3 and 20,22(OH)2L3. (A), RORγ transactivation assay in Tet-on CHO cells. To induce expression of RORγ protein expression, CHO cells were treated with 1 μM doxycycline for 24 h. To measure the transactivation the cells were treated with graded concentrations of the hydroxylumisterols listed, and the RORE-mediated activation of the luciferase reporter activity was assayed with a Luciferase Assay Substrate kit (Promega) as described previously24. Assays were performed in triplicate. (B), RORα coactivator assay using LanthaScreen TR-FRET RORα Coactivator kit assay. RORα-LBD was added to graded concentrations of hydroxylumisterols followed by the addition of a mixture of peptide (TRAP220/DRIP2) and antibody (Tb-anti-GST). The reaction mixture was incubated at room temperature for 2 h and the TR-FRET ratio was calculated by dividing the fluorescein emission at 520 nm by the Terbium emission at 495 nm using Synergy neo2 (BioTek Instruments, Inc., Winooski, VT). Data represent means ± SE (n ≥ 3) where *p < 0.05, **p < 0.01 and ***p < 0.001 student t-test; #p < 0.05, ##p < 0.01, ###p < 0.001 and ####p < 0.0001 by one-way ANOVA and general ANOVA tests are shown. (C), RORE luciferase assay in HaCaT keratinocytes. The cells were cotransfected with the reporter plasmids pGL4.27-(RORE)5 and phRL-TK (Promega) using Lipofectamine (Invitrogen, Carlsbad, CA) following the manufacturer’s protocol. After transfection, the cells were treated with hydroxylumisterols for 48 h. Luciferase reporter activity was measured using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI). Firefly and Renilla signals were read using Cytation 5 (BioTek Instruments, Inc., Winooski, VT), and the ratios were calculated.
Figure 6 Modulation of RORα and RORγ activities by 20(OH)L3, 22(OH)L3, 24(OH)L3 and 20,22(OH)2L3. (A), RORγ transactivation assay in Tet-on CHO cells. To induce expression of RORγ protein expression, CHO cells were treated with 1 μM doxycycline for 24 h. To measure the transactivation the cells were treated with graded concentrations of the hydroxylumisterols listed, and the RORE-mediated activation of the luciferase reporter activity was assayed with a Luciferase Assay Substrate kit (Promega) as described previously24. Assays were performed in triplicate. (B), RORα coactivator assay using LanthaScreen TR-FRET RORα Coactivator kit assay. RORα-LBD was added to graded concentrations of hydroxylumisterols followed by the addition of a mixture of peptide (TRAP220/DRIP2) and antibody (Tb-anti-GST). The reaction mixture was incubated at room temperature for 2 h and the TR-FRET ratio was calculated by dividing the fluorescein emission at 520 nm by the Terbium emission at 495 nm using Synergy neo2 (BioTek Instruments, Inc., Winooski, VT). Data represent means ± SE (n ≥ 3) where *p < 0.05, **p < 0.01 and ***p < 0.001 student t-test; #p < 0.05, ##p < 0.01, ###p < 0.001 and ####p < 0.0001 by one-way ANOVA and general ANOVA tests are shown. (C), RORE luciferase assay in HaCaT keratinocytes. The cells were cotransfected with the reporter plasmids pGL4.27-(RORE)5 and phRL-TK (Promega) using Lipofectamine (Invitrogen, Carlsbad, CA) following the manufacturer’s protocol. After transfection, the cells were treated with hydroxylumisterols for 48 h. Luciferase reporter activity was measured using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI). Firefly and Renilla signals were read using Cytation 5 (BioTek Instruments, Inc., Winooski, VT), and the ratios were calculated.CC BY · PubMed Central
Figure 7 Docking results using the crystal structure of RORα. (a). The ligand binding site of RORα with the docked pose of lumisterol. Residues mapping the active site are shown; protein carbons are colored dark green, ligand carbons pink, all other atoms by atom type (O red, N blue, S yellow, H white). The dashed line indicates hydrogen bonding between lumisterol and Tyr380 (2.1 Å distance between interacting atoms). (b-c). The overlap of docked poses is illustrated in the RORα binding site in comparison with the co-crystallized 20-hydroxycholesterol. (b) Cholesterol analogs (purple carbons) and (c) Hydroxylumisterol analogs (pink carbons). The co-crystallized cholesterol is shown with light green carbons. Only residues that may contribute to polar interactions are shown; dashed lines indicate hydrogen bonds. (d) The ‘flipped’ pose of hydroxylated pregnalumisterol (pL) analogs binding to RORα. Carbon atoms of ligands are color-coded as shown; protein carbons are dark green (all other atoms are colored by atom type). Hydrogen bonding interactions are shown with dashed lines. Interactions contributed by the 20-OH group of 17, 20(OH)2pL enantiomers: (S)20-OH forms a water-bridged hydrogen bond with R370; (R)20-OH participates in hydrogen bonding with the backbone carbonyl of Val364.
Figure 7 Docking results using the crystal structure of RORα. (a). The ligand binding site of RORα with the docked pose of lumisterol. Residues mapping the active site are shown; protein carbons are colored dark green, ligand carbons pink, all other atoms by atom type (O red, N blue, S yellow, H white). The dashed line indicates hydrogen bonding between lumisterol and Tyr380 (2.1 Å distance between interacting atoms). (b-c). The overlap of docked poses is illustrated in the RORα binding site in comparison with the co-crystallized 20-hydroxycholesterol. (b) Cholesterol analogs (purple carbons) and (c) Hydroxylumisterol analogs (pink carbons). The co-crystallized cholesterol is shown with light green carbons. Only residues that may contribute to polar interactions are shown; dashed lines indicate hydrogen bonds. (d) The ‘flipped’ pose of hydroxylated pregnalumisterol (pL) analogs binding to RORα. Carbon atoms of ligands are color-coded as shown; protein carbons are dark green (all other atoms are colored by atom type). Hydrogen bonding interactions are shown with dashed lines. Interactions contributed by the 20-OH group of 17, 20(OH)2pL enantiomers: (S)20-OH forms a water-bridged hydrogen bond with R370; (R)20-OH participates in hydrogen bonding with the backbone carbonyl of Val364.CC BY · PubMed Central
Figure 8 Docked poses in the RORγ binding site and comparison with inverse agonist bound crystal structures. (a) Docked lumisterol in the RORγ active site is shown in comparison with the co-crystallized 20-hydroxycholesterol (light green colored carbons). Similar view angle and the same color coding is used as in case of RORα (Fig. 7a). Hydrogen bonding interactions are indicated with dashed lines. (b) The overlap of docked poses is illustrated for hydroxylumisterols (20(OH)L3, 22(OH)L3, 24(OH)L3, 20,22(OH)2L3) with pink color carbons while cholesterol is shown with thick bonds and carbons colored maroon. Key residues involved in inverse agonism of co-crystallized ligands are shown only. Residues in the RORγ crystal structure used in our docking study are displayed with dark green carbons (PDB code 3KYT); residues in RORγ structures co-crystallized with inverse agonist ligands are shown with brown colored carbons (PDB codes 3B0W, 4NB6, 4WQP). Using the same view angle and orientation the inset illustrates 20-hydroxylumisterol in comparison with an inverse agonist ligand co-crystallized in RORγ (PDB code 4WQP), shown with brown colored carbons. The analog of this ligand lacking the one-carbon linker marked with a red arrow is a RORγ agonist. (c) RORγ crystal structures with inverse agonists are aligned onto the structure with PDB code 3KYT. The three key residues (as in Fig. 8b) are also shown, along with co-crystallized ligands from two structures: PDB codes 3KYT and 4WQP. Font colors of PDB codes listed correspond to the coloring of secondary structures and carbon atoms of co-crystallized ligands shown.
Figure 8 Docked poses in the RORγ binding site and comparison with inverse agonist bound crystal structures. (a) Docked lumisterol in the RORγ active site is shown in comparison with the co-crystallized 20-hydroxycholesterol (light green colored carbons). Similar view angle and the same color coding is used as in case of RORα (Fig. 7a). Hydrogen bonding interactions are indicated with dashed lines. (b) The overlap of docked poses is illustrated for hydroxylumisterols (20(OH)L3, 22(OH)L3, 24(OH)L3, 20,22(OH)2L3) with pink color carbons while cholesterol is shown with thick bonds and carbons colored maroon. Key residues involved in inverse agonism of co-crystallized ligands are shown only. Residues in the RORγ crystal structure used in our docking study are displayed with dark green carbons (PDB code 3KYT); residues in RORγ structures co-crystallized with inverse agonist ligands are shown with brown colored carbons (PDB codes 3B0W, 4NB6, 4WQP). Using the same view angle and orientation the inset illustrates 20-hydroxylumisterol in comparison with an inverse agonist ligand co-crystallized in RORγ (PDB code 4WQP), shown with brown colored carbons. The analog of this ligand lacking the one-carbon linker marked with a red arrow is a RORγ agonist. (c) RORγ crystal structures with inverse agonists are aligned onto the structure with PDB code 3KYT. The three key residues (as in Fig. 8b) are also shown, along with co-crystallized ligands from two structures: PDB codes 3KYT and 4WQP. Font colors of PDB codes listed correspond to the coloring of secondary structures and carbon atoms of co-crystallized ligands shown.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

13 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 1

  1. Kim, T.-K. et al. Correlation between secosteroid induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol Cell Endocrinol 361, 143–152, doi:10.1016/j.mce.2012.04.001 (2012). · DOI · Paper page

Cited by

See all 83

Metadata

Authors
Slominski, A. T., Kim, T.-K., Hobrath, J. V., Janjetovic, Z., Oak, A. S. W., Postlethwaite, A., Lin, Z., Li, W., Takeda, Y., Jetten, A. M., & Tuckey, R. C.
Affiliations
  • University of Alabama at Birmingham (US)
  • Birmingham VA Medical Center (US)
  • University of Dundee (GB)
  • University of Tennessee Health Science Center (US)
  • National Institutes of Health (US)
  • The University of Western Australia (AU)
Corresponding author
Slominski, Andrzej T.
Venue
Scientific Reports
Published
2017-09-12
Volume
7
Issue
1
Pages
11434-11434
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2751533291
Cited by
82
References
70
Citations by year
2026: 4 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 16 · 2020: 12 · 2019: 13 · 2018: 8
FWCI
9.25
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
Funders
  • U.S. Department of Veterans Affairs (IP1 BX001607, I01 CX001400)
  • National Institutes of Health (1s10od010678-01, Z01-ES-101586)
  • National Institute of Environmental Health Sciences (Z01ES101586)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR066505, R21AR063242, R01AR071189, R01AR056666)
  • National Center for Research Resources (S10RR026377)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
Keywords
lumisterol, RORα, RORγ, keratinocyte differentiation, melanoma cell proliferation, epidermis, adrenal gland, skin cells, gene expression, vitamin D metabolites
MeSH terms
Animals, Chromatography, Liquid, Dose-Response Relationship, Drug, Epidermis, Ergosterol, Humans, Models, Molecular, Molecular Conformation, Swine, Molecular Structure, Biomarkers, Keratinocytes, Receptors, Calcitriol, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Cell Line, Tumor, Metabolic Networks and Pathways, Nuclear Receptor Subfamily 1, Group F, Member 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols. https://app.cochat.ai/papers/10.1038/s41598-017-10202-7
The paper
Slominski, A. T., Kim, T.-K., Hobrath, J. V., Janjetovic, Z., Oak, A. S. W., Postlethwaite, A., Lin, Z., Li, W., Takeda, Y., Jetten, A. M., & Tuckey, R. C. (2017). Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols. Scientific Reports. https://doi.org/10.1038/s41598-017-10202-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.